BRC Therapeutics is a pharmaceutical company headquartered in Castroville, California. The company focuses on developing proprietary cannabinoid therapeutics and innovative treatments to provide relief from pain and neurological conditions.
Subscribe to see BRC Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BRC Therapeutics is a drug discovery company headquartered in United States. Xcout tracks 9 named people at BRC Therapeutics, including David Weinmann (Finance).
3 more named people on record for BRC Therapeutics, with roles, board committees and tenure — see the full roster →
A few of BRC Therapeutics's closest competitors — see the full list of competitors and alternatives →
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Object Pharma is a privately held biopharmaceutical company headquartered in Aliso Viejo, California, founded in 2018. The company is dedicated to developing novel treatments for mental health disorders and manufactures botulinum toxin products for accredited research use.
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Tortugas Neuroscience is a drug discovery and biopharmaceutical company headquartered in Framingham, Massachusetts. The company focuses on advancing innovative neuroscience therapeutics.
EpiBiologics, Inc. is a biotechnology company headquartered in San Mateo, California, focused on drug pipelines and therapeutic developments.
Sarcomatrix Therapeutics Corp. is a biopharmaceutical and biotechnology research company headquartered in Reno, Nevada. The company is dedicated to pioneering muscle regeneration therapies and advancing novel therapeutics to treat muscle-wasting diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.